These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 21155383)
21. S 18126 ([2-[4-(2,3-dihydrobenzo[1,4]dioxin-6-yl)piperazin-1-yl methyl]indan-2-yl]), a potent, selective and competitive antagonist at dopamine D4 receptors: an in vitro and in vivo comparison with L 745,870 (3-(4-[4-chlorophenyl]piperazin-1-yl)methyl-1H-pyrrolo[2, 3b]pyridine) and raclopride. Millan MJ; Newman-Tancredi A; Brocco M; Gobert A; Lejeune F; Audinot V; Rivet JM; Schreiber R; Dekeyne A; Spedding M; Nicolas JP; Peglion JL J Pharmacol Exp Ther; 1998 Oct; 287(1):167-86. PubMed ID: 9765336 [TBL] [Abstract][Full Text] [Related]
22. Dopamine D4-like receptors in vertebrate retina: does the retina offer a model for the D4-receptor analysis? Zawilska JB; Nowak JZ Pol J Pharmacol; 1997 Aug; 49(4):201-11. PubMed ID: 9437763 [TBL] [Abstract][Full Text] [Related]
24. [Functional role of dopamine D4 receptor in schizophrenia]. Semba J Nihon Shinkei Seishin Yakurigaku Zasshi; 2004 Feb; 24(1):13-20. PubMed ID: 15027326 [TBL] [Abstract][Full Text] [Related]
25. Synthesis and pharmacology of trans-4-n-propyl-3,4,4a,10b-tetrahydro-2H,5H-1-benzopyrano[4,3-b ]-1,4-oxazin-7- and -9-ols: the significance of nitrogen pKa values for central dopamine receptor activation. Dijkstra D; Mulder TB; Rollema H; Tepper PG; Van der Weide J; Horn AS J Med Chem; 1988 Nov; 31(11):2178-82. PubMed ID: 2903247 [TBL] [Abstract][Full Text] [Related]
26. Biological profile of L-745,870, a selective antagonist with high affinity for the dopamine D4 receptor. Patel S; Freedman S; Chapman KL; Emms F; Fletcher AE; Knowles M; Marwood R; Mcallister G; Myers J; Curtis N; Kulagowski JJ; Leeson PD; Ridgill M; Graham M; Matheson S; Rathbone D; Watt AP; Bristow LJ; Rupniak NM; Baskin E; Lynch JJ; Ragan CI J Pharmacol Exp Ther; 1997 Nov; 283(2):636-47. PubMed ID: 9353380 [TBL] [Abstract][Full Text] [Related]
28. Novel heterocyclic trans olefin analogues of N-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl}arylcarboxamides as selective probes with high affinity for the dopamine D3 receptor. Grundt P; Carlson EE; Cao J; Bennett CJ; McElveen E; Taylor M; Luedtke RR; Newman AH J Med Chem; 2005 Feb; 48(3):839-48. PubMed ID: 15689168 [TBL] [Abstract][Full Text] [Related]
29. Electrostatic surface potential calculation on several new halogenated benzimidazole-like dopaminergic ligands. Sukalović V; Andrić D; Roglić G; Kostić-Rajaccić S; Soskić V Arch Pharm (Weinheim); 2004 Jul; 337(7):376-82. PubMed ID: 15237387 [TBL] [Abstract][Full Text] [Related]
30. Synthesis and biological activity of cocaine analogues. 2. 6H-[2]Benzopyrano[4,3-c]pyridin-6-ones. Lazer ES; Hite GJ; Nieforth KA; Stratford ES J Med Chem; 1979 Jul; 22(7):845-9. PubMed ID: 448684 [TBL] [Abstract][Full Text] [Related]
31. Design, synthesis and dopamine D4 receptor binding activities of new N-heteroaromatic 5/6-ring Mannich bases. Linz S; Müller J; Hübner H; Gmeiner P; Troschütz R Bioorg Med Chem; 2009 Jul; 17(13):4448-58. PubMed ID: 19481941 [TBL] [Abstract][Full Text] [Related]
32. Fancy bioisosteres: metallocene-derived G-protein-coupled receptor ligands with subnanomolar binding affinity and novel selectivity profiles. Schlotter K; Boeckler F; Hübner H; Gmeiner P J Med Chem; 2005 Jun; 48(11):3696-9. PubMed ID: 15916420 [TBL] [Abstract][Full Text] [Related]
33. Synthesis of novel lactam derivatives and their evaluation as ligands for the dopamine receptors, leading to a D(4)-selective ligand. Awadallah FM; Müller F; Lehmann J; Abadi AH Bioorg Med Chem; 2007 Sep; 15(17):5811-8. PubMed ID: 17576067 [TBL] [Abstract][Full Text] [Related]
34. Investigation of mixed D2/5-HT1A activity of N-heteroarylmethyl-N-phenylpiperazines, N-heteroarylethyl-N-phenylpiperazines and N-heteroarylpropyl-N-phenylpiperazines. Roglić G; Dukić-Stefanović S; Andrić D; Kostić-Rajacić S; Soskić V Pharmazie; 2001 Oct; 56(10):803-7. PubMed ID: 11683128 [TBL] [Abstract][Full Text] [Related]
35. Functional activation by central monoamines of human dopamine D(4) receptor polymorphic variants coupled to GIRK channels in Xenopus oocytes. Wedemeyer C; Goutman JD; Avale ME; Franchini LF; Rubinstein M; Calvo DJ Eur J Pharmacol; 2007 May; 562(3):165-73. PubMed ID: 17350612 [TBL] [Abstract][Full Text] [Related]
36. In vivo evaluation of [(123)I]-3-(4-iodobenzyl)-1,2,3,4-tetrahydro-8-hydroxychromeno[3,4-c]pyridin-5-one: a presumed dopamine D4 receptor ligand for SPECT studies. Staelens L; Oltenfreiter R; Blanckaert P; Kersemans V; Vandenbulcke K; Van De Wiele C; Slegers G Nucl Med Biol; 2005 Apr; 32(3):293-9. PubMed ID: 15820765 [TBL] [Abstract][Full Text] [Related]
37. Dopamine D3 and D4 receptor antagonists in the treatment of schizophrenia. Jardemark K; Wadenberg ML; Grillner P; Svensson TH Curr Opin Investig Drugs; 2002 Jan; 3(1):101-5. PubMed ID: 12054059 [TBL] [Abstract][Full Text] [Related]
38. Synthesis and dopaminergic features of six novel 3-arylpiperidines. Kostic-Rajacic A; Soskic V; Joksimovic J Boll Chim Farm; 1998 Nov; 137(10):417-21. PubMed ID: 10025971 [TBL] [Abstract][Full Text] [Related]
39. Synthesis and in vitro binding of N-phenyl piperazine analogs as potential dopamine D3 receptor ligands. Chu W; Tu Z; McElveen E; Xu J; Taylor M; Luedtke RR; Mach RH Bioorg Med Chem; 2005 Jan; 13(1):77-87. PubMed ID: 15582454 [TBL] [Abstract][Full Text] [Related]
40. A-412997 is a selective dopamine D4 receptor agonist in rats. Moreland RB; Patel M; Hsieh GC; Wetter JM; Marsh K; Brioni JD Pharmacol Biochem Behav; 2005 Sep; 82(1):140-7. PubMed ID: 16153699 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]